Cochrane · systematic review · CD008369

Astragalus (a traditional Chinese medicine) for treating chronic kidney disease

Zhang, HW, Lin, ZX, Xu, C, et al. · Cochrane Database of Systematic Reviews · 2014 · Cochrane Library

Kidney and TransplantAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
5
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 2 · 28.6%Very low 0 · 0%Low 4 · 57.1%Moderate 1 · 14.3%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Astragalus and co‐interventions compared with same co‐interventions alone for people with CKD

Population: patients with CKD
7 questions
OutcomeEffectEvidenceStatus / GRADE
Time to requirement for RRT/initiation of dialysis
Astragalus and co‐interventions vs same co‐interventions alone
no estimate extracted0 studies · 0 participantsUngraded
All‐cause mortality
Astragalus and co‐interventions vs same co‐interventions alone
no estimate extracted0 studies · 0 participantsUngraded
Creatinine clearance (after treatment)
Astragalus and co‐interventions vs same co‐interventions alone
no estimate extracted4 studies · 306 participantsLow
Serum creatinine (after treatment)
Astragalus and co‐interventions vs same co‐interventions alone
no estimate extracted14 studies · 841 participantsLow
h proteinuria (after treatment)
Astragalus and co‐interventions vs same co‐interventions alone
no estimate extracted11 studies · 706 participantsLow
Albumin
Astragalus and co‐interventions vs same co‐interventions alone
no estimate extracted10 studies · 588 participantsLow
Haemoglobin
Astragalus and co‐interventions vs same co‐interventions alone
no estimate extracted4 studies · 222 participantsModerate